Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study [Yahoo! Finance]
Seer, Inc. - Class A (SEER)
Company Research
Source: Yahoo! Finance
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to date utilizing the Seer Proteograph™ Product Suite and Thermo Fisher Scientific's Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer. This pioneering research involved a multi-cancer case-control cohort of 2,840 subjects, achieving the detection of over 13,000 protein groups in plasma across the study, with an average of over 8,200 protein groups in plasma per sample. PrognomiQ collected blood samples across 77 clinical sites in the U.S., and processed plasma samples using their in-house Seer Proteograph SP100 instruments and XT assays. The resulting peptides were sent to the Seer Technology Access Center (STAC) in Redwood City to be analyzed using the Orbitrap Astral mass spectrometers.
Show less
Read more
Impact Snapshot
Event Time:
SEER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SEER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SEER alerts
High impacting Seer, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
SEER
News
- Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery [Yahoo! Finance]Yahoo! Finance
- Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker DiscoveryGlobeNewswire
- Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection StudyGlobeNewswire
- Seer, Inc. (NASDAQ:SEER) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Seer, Inc. (SEER) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
SEER
Earnings
- 5/8/24 - Miss
SEER
Sec Filings
- 6/18/24 - Form 4
- 6/14/24 - Form 8-K
- 6/14/24 - Form 4
- SEER's page on the SEC website